Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Peter B. Gregory, M.D Professor of Medicine, Emeritus Education 1959 B.A. 1963 M.D. 1963-64 1966-67 1967-68 1968-69 1969-70 1970-71 (Chemistry) Yale University, New Haven, Connecticut cum laude, Yale School of Medicine, New Haven,Connecticut Internship (Medicine), Grace New Haven Community Hospital First Year Resident (Medicine), Yale New Haven Medical Center Senior Resident (Medicine), Stanford Medical Center, Stanford, CA. Chief Resident (Medicine), Stanford Medical Center, Stanford, CA. Fellow (Liver), Yale University Hospital, New Haven, Conn. Fellow (Gastroenterology), Stanford Medical Center, Stanford, CA. Research and Professional Experience 1962 The Ramsey Memorial Scholarship Prize (Yale School of Medicine) 1963 The Parker Prize (Yale School of Medicine) 1962-63 A.O.A. 1964-66 Research Associate, Atomic Bomb Casualty Commission, Hiroshima, Japan (USPHS) 1971-72 Instructor of Medicine, Stanford University School of Medicine, Stanford, California 1972-77 Academic Career Development Award, NIAMD-USPHS AM 70318 1972-78 Assistant Professor of Medicine, Stanford University School of Medicine, Stanford, California 1978-83 Associate Professor of Clinical Medicine, Stanford University School of Medicine, Stanford, California 1979-87 Section Chief, Gastroenterology, VAMC, Palo Alto, California 1983-02 Professor of Medicine (Clinical), Stanford University School of Medicine, Stanford, California. 1987-89 Associate Dean for Graduate Medical Education, Stanford University School of Medicine, Stanford, California. 1990-97 Associate Dean for Clinical Affairs, Medical Director, Faculty Practice Program 1994-97 Chief Medical Officer, Stanford Health Services 1997-01 Senior Associate Dean for Clinical Affairs 1999-01 Chief Medical Officer, Stanford Hospital and Clinics 2002Professor of Medicine (Clinical), Emeritus, Stanford University School of Medicine, Stanford, California. PUBLICATIONS (selected) Gregory PB, Knauer CM, Kempson RL, and Miller R. Steroid therapy in severe viral hepatitis: A double-blind, randomized trial of methylprednisolone versus placebo. N.E.J.M. 294;681-686, 1976. Gregory PB, Broekelschen PH, Hill MD, Lipton AB, Knauer CM, Egger M, Miller R. The complications of diuresis in the alcoholic patient with ascites: A controlled trial. Gastroenterology 73;534-538, 1977. Gregory PB, Knauer CM, Fogel MR, Andres LL, Rinki MM, Walker JE. Upper gastrointestinal bleeding: Accuracy of clinical diagnosis and prognosis. Digestive Diseases and Sciences 26:65s-69s, 1981. Fogel MR, Knauer CM, Andres LL, Mahal AS, Stein DET, Kemeny MJ, Rinki MM, Walker JE, Siegmund D, Gregory PB. Continuous intravenous vasopressin in active upper gastrointestinal bleeding: A placebo-controlled trial. Annals of Internal Medicine 96:565-569, l982. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB. Survival in chronic hepatitis B: an analysis of three hundred seventy-nine patients. Annals of Internal Medicine 101:613616, 1984. Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Mastre B, Rosno S, Roskamp D, Waterman K, Pollard RB, Tong MJ, Brown BW, Robinson WS, Gregory PB, Merigan TC. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B: A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 107:278-285, 1987. Bissett J, Eisenberg M, Gregory P, Robinson WS, Merigan TC. Recombinant Fibroblast Interferon and Immune Interferon for Treating Chronic Hepatitis B Virus Infection: Patients' Tolerance and the Effect on Viral Markers. The Journal of Infectious Diseases, 157:1076-80, 1988 Gregory P and the Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic Sclerotherapy for Esophageal Varices in Men with Alcoholic Liver Disease: A Randomized, Single-blind, Multicenter Clinical Trial. New England Journal of Medicine 324:1779-84, 1991 Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon G, Rinki M, Sucher K, Gregory P. Accelerated Improvement of Alcoholic Liver Disease with Enteral Nutrition. Gastroenterology ,102:200-05, 1992 Gregory P and the Veterans Affairs Cooperative Variceal Sclerotherapy Group. Sclerotherapy for Male Alcoholic Cirrhotic Patients who have bled from esophageal varices: Results of a Randomized, Multicenter Clinical Trial. Hepatology 20:618-25, 1994) (1) Currently Active Support None